josh maxwell
Wake Forest Institute for Regenerative Medicine, School of Medicine, Wake Forest University
Winston-Salem, United States
Review Editor
Cardiovascular and Hematologic Drugs
Wake Forest Institute for Regenerative Medicine, School of Medicine, Wake Forest University
Winston-Salem, United States
Review Editor
Cardiovascular and Hematologic Drugs
The Johns Hopkins Hospital, Johns Hopkins Medicine
Baltimore, United States
Review Editor
Cardiovascular and Hematologic Drugs
University of Washington
Seattle, United States
Review Editor
Cardiovascular and Hematologic Drugs
Loyola University Chicago
Chicago, United States
Review Editor
Cardiovascular and Hematologic Drugs
Vanderbilt University Medical Center
Nashville, United States
Review Editor
Cardiovascular and Hematologic Drugs
University Health Network (UHN)
Toronto, Canada
Review Editor
Cardiovascular and Hematologic Drugs
German Heart Center Charité Berlin
Berlin, Germany
Review Editor
Cardiovascular and Hematologic Drugs
Margarita Salas Center for Biological Research, Spanish National Research Council (CSIC)
Madrid, Spain
Review Editor
Cardiovascular and Hematologic Drugs
University of California, Los Angeles
Los Angeles, United States
Review Editor
Cardiovascular and Hematologic Drugs
Stanford Cardiovascular Institute
Stanford, United States
Review Editor
Cardiovascular and Hematologic Drugs
The University of Utah
Salt Lake City, United States
Review Editor
Cardiovascular and Hematologic Drugs
Oklahoma Medical Research Foundation
Oklahoma City, United States
Review Editor
Cardiovascular and Hematologic Drugs
University of Kiel
Kiel, Germany
Review Editor
Cardiovascular and Hematologic Drugs
University of Liverpool
Liverpool, United Kingdom
Review Editor
Cardiovascular and Hematologic Drugs
Columbia University Irving Medical Center, Columbia University
New York, United States
Review Editor
Cardiovascular and Hematologic Drugs
College of Medicine, The Ohio State University
Columbus, United States
Review Editor
Cardiovascular and Hematologic Drugs